Saturday, December 13, 2014

HFF closes sale of BioMed Realty Trust life sciences facility in Rockville, MD

                                                 
9911 Belward Campus Drive, Rockville, MD

Stephen Conley
WASHINGTON, D.C. – HFF announced the sale of 9911 Belward Campus Drive, a 289,912-square-foot large scale biologics manufacturing facility in Rockville, Maryland, that is 100-percent leased through May 2026 to Human Genome Sciences, Inc., a wholly owned subsidiary of GlaxoSmithKline (NYSE: GSK). 

               HFF marketed the property on behalf of the owner, BioMed Realty Trust.  The asset was purchased for an undisclosed amount. 

9911 Belward Campus Drive is the single point of production for GSK’s FDA-approved lupus treatment Benlysta.  Completed in 2005, the large scale manufacturing site has a fully-integrated warehouse with production and testing capabilities enabling stand-alone production of commercial biologics derived from cell culture.

 The facility sits on a 9.55 acre site at the intersection of Interstate 270 and Shady Grove Road in Rockville, which is two miles south of the newly-opened Intercounty Connector and approximately 20 miles northwest of downtown Washington, D.C. 

Jim Meisel
The HFF investment sales team representing the seller was led by executive managing director Stephen Conley, senior managing directors Jim Meisel, Dek Potts and Andrew Weir, associate director Matt Nicholson and senior real estate analyst Dave Baker.

“This is a very special purpose facility that provides stable cash on cash yields from an investment grade tenant for more than 10 years,” Meisel said.

BioMed Realty Trust, Inc. (NYSE: BMR), is a leading provider of real estate solutions to the life science community and offers leasing, development, construction, redevelopment, acquisition, financing and property management services to its tenant partners in the United States and the United Kingdom. 

BioMed Realty owns or has interests in properties comprising approximately 17.2 million rentable square feet. 

Additional information is available at www.biomedrealty.com.  Follow them on Twitter@BioMedRealty.

For a complete copy of the company’s news release, please contact:

Kristen M. Murphy
Associate Director
HFF | One Post Office Square, Suite 3500 | Boston, MA 02109
Main: 617-338-0990 | Direct: 617-848-1572 | Cell: 617-543-4873 | www.hfflp.com

No comments: